Tilray, Inc.
(Swiss Exchange : TLRY)

( )
TLRY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.38%194.911.2%$602.16m
GILDGilead Sciences, Inc.
-0.78%67.480.9%$499.30m
CELGCelgene Corporation
-0.19%69.271.2%$492.42m
BIIBBiogen Inc.
0.01%319.251.3%$467.66m
ILMNIllumina, Inc.
-5.73%301.593.5%$381.70m
REGNRegeneron Pharmaceuticals, Inc.
0.00%338.992.6%$298.67m
VRTXVertex Pharmaceuticals Incorporated
-2.45%161.071.9%$260.54m
ALXNAlexion Pharmaceuticals, Inc.
-3.00%115.062.0%$199.08m
AAgilent Technologies, Inc.
-3.72%62.571.5%$185.86m
SRPTSarepta Therapeutics, Inc.
-2.25%116.3615.4%$146.77m
LGNDLigand Pharmaceuticals Incorporated
-3.83%148.5423.3%$139.57m
EXASExact Sciences Corporation
0.00%67.2825.3%$137.02m
NKTRNektar Therapeutics
-0.05%37.995.6%$122.18m
INCYIncyte Corporation
-3.40%64.252.5%$115.74m
TSROTESARO, Inc.
-0.41%36.6814.4%$108.95m

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.